S Di Blasi, S Pintacuda, N Ferotti, L Lo Coco, A Muratore, G Russo, U Di Blasi, M D'Alessandro, G Morici, M Fornaciari
{"title":"[吲哚布芬对血栓形成危险受试者血小板功能若干参数的长期影响]。","authors":"S Di Blasi, S Pintacuda, N Ferotti, L Lo Coco, A Muratore, G Russo, U Di Blasi, M D'Alessandro, G Morici, M Fornaciari","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Indobufen (200 mg b.i.d., by os, for 21 days) was gave to 16 patients with atherothrombotic risk in which platelet function was valued. In this subjects, indobufen significatively reduced platelet aggregation, beta-thromboglobulin, platelet factor the 4th and alpha-platelet granules' intake. No side effects were found.</p>","PeriodicalId":12732,"journal":{"name":"Giornale di clinica medica","volume":"71 12","pages":"727-31"},"PeriodicalIF":0.0000,"publicationDate":"1990-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].\",\"authors\":\"S Di Blasi, S Pintacuda, N Ferotti, L Lo Coco, A Muratore, G Russo, U Di Blasi, M D'Alessandro, G Morici, M Fornaciari\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Indobufen (200 mg b.i.d., by os, for 21 days) was gave to 16 patients with atherothrombotic risk in which platelet function was valued. In this subjects, indobufen significatively reduced platelet aggregation, beta-thromboglobulin, platelet factor the 4th and alpha-platelet granules' intake. No side effects were found.</p>\",\"PeriodicalId\":12732,\"journal\":{\"name\":\"Giornale di clinica medica\",\"volume\":\"71 12\",\"pages\":\"727-31\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale di clinica medica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale di clinica medica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
Indobufen (200 mg b.i.d., by os, for 21 days) was gave to 16 patients with atherothrombotic risk in which platelet function was valued. In this subjects, indobufen significatively reduced platelet aggregation, beta-thromboglobulin, platelet factor the 4th and alpha-platelet granules' intake. No side effects were found.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
